Cargando…

Multi ‘Omics Analysis of Intestinal Tissue in Ankylosing Spondylitis Identifies Alterations in the Tryptophan Metabolism Pathway

Intestinal microbial dysbiosis, intestinal inflammation, and Th17 immunity are all linked to the pathophysiology of spondyloarthritis (SpA); however, the mechanisms linking them remain unknown. One potential hypothesis suggests that the dysbiotic gut microbiome as a whole produces metabolites that i...

Descripción completa

Detalles Bibliográficos
Autores principales: Berlinberg, Adam J., Regner, Emilie H., Stahly, Andrew, Brar, Ana, Reisz, Julie A., Gerich, Mark E., Fennimore, Blair P., Scott, Frank I., Freeman, Alison E., Kuhn, Kristine A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966505/
https://www.ncbi.nlm.nih.gov/pubmed/33746944
http://dx.doi.org/10.3389/fimmu.2021.587119
_version_ 1783665699480141824
author Berlinberg, Adam J.
Regner, Emilie H.
Stahly, Andrew
Brar, Ana
Reisz, Julie A.
Gerich, Mark E.
Fennimore, Blair P.
Scott, Frank I.
Freeman, Alison E.
Kuhn, Kristine A.
author_facet Berlinberg, Adam J.
Regner, Emilie H.
Stahly, Andrew
Brar, Ana
Reisz, Julie A.
Gerich, Mark E.
Fennimore, Blair P.
Scott, Frank I.
Freeman, Alison E.
Kuhn, Kristine A.
author_sort Berlinberg, Adam J.
collection PubMed
description Intestinal microbial dysbiosis, intestinal inflammation, and Th17 immunity are all linked to the pathophysiology of spondyloarthritis (SpA); however, the mechanisms linking them remain unknown. One potential hypothesis suggests that the dysbiotic gut microbiome as a whole produces metabolites that influence human immune cells. To identify potential disease-relevant, microbiome-produced metabolites, we performed metabolomics screening and shotgun metagenomics on paired colon biopsies and fecal samples, respectively, from subjects with axial SpA (axSpA, N=21), Crohn’s disease (CD, N=27), and Crohn’s-axSpA overlap (CD-axSpA, N=12), as well as controls (HC, N=24). Using LC-MS based metabolomics of 4 non-inflamed pinch biopsies of the distal colon from subjects, we identified significant alterations in tryptophan pathway metabolites, including an expansion of indole-3-acetate (IAA) in axSpA and CD-axSpA compared to HC and CD and indole-3-acetaldehyde (I3Ald) in axSpA and CD-axSpA but not CD compared to HC, suggesting possible specificity to the development of axSpA. We then performed shotgun metagenomics of fecal samples to characterize gut microbial dysbiosis across these disease states. In spite of no significant differences in alpha-diversity among the 4 groups, our results confirmed differences in gene abundances of numerous enzymes involved in tryptophan metabolism. Specifically, gene abundance of indolepyruvate decarboxylase, which generates IAA and I3Ald, was significantly elevated in individuals with axSpA while gene abundances in HC demonstrated a propensity towards tryptophan synthesis. Such genetic changes were not observed in CD, again suggesting disease specificity for axSpA. Given the emerging role of tryptophan and its metabolites in immune function, altogether these data indicate that tryptophan metabolism into I3Ald and then IAA is one mechanism by which the gut microbiome potentially influences the development of axSpA.
format Online
Article
Text
id pubmed-7966505
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79665052021-03-18 Multi ‘Omics Analysis of Intestinal Tissue in Ankylosing Spondylitis Identifies Alterations in the Tryptophan Metabolism Pathway Berlinberg, Adam J. Regner, Emilie H. Stahly, Andrew Brar, Ana Reisz, Julie A. Gerich, Mark E. Fennimore, Blair P. Scott, Frank I. Freeman, Alison E. Kuhn, Kristine A. Front Immunol Immunology Intestinal microbial dysbiosis, intestinal inflammation, and Th17 immunity are all linked to the pathophysiology of spondyloarthritis (SpA); however, the mechanisms linking them remain unknown. One potential hypothesis suggests that the dysbiotic gut microbiome as a whole produces metabolites that influence human immune cells. To identify potential disease-relevant, microbiome-produced metabolites, we performed metabolomics screening and shotgun metagenomics on paired colon biopsies and fecal samples, respectively, from subjects with axial SpA (axSpA, N=21), Crohn’s disease (CD, N=27), and Crohn’s-axSpA overlap (CD-axSpA, N=12), as well as controls (HC, N=24). Using LC-MS based metabolomics of 4 non-inflamed pinch biopsies of the distal colon from subjects, we identified significant alterations in tryptophan pathway metabolites, including an expansion of indole-3-acetate (IAA) in axSpA and CD-axSpA compared to HC and CD and indole-3-acetaldehyde (I3Ald) in axSpA and CD-axSpA but not CD compared to HC, suggesting possible specificity to the development of axSpA. We then performed shotgun metagenomics of fecal samples to characterize gut microbial dysbiosis across these disease states. In spite of no significant differences in alpha-diversity among the 4 groups, our results confirmed differences in gene abundances of numerous enzymes involved in tryptophan metabolism. Specifically, gene abundance of indolepyruvate decarboxylase, which generates IAA and I3Ald, was significantly elevated in individuals with axSpA while gene abundances in HC demonstrated a propensity towards tryptophan synthesis. Such genetic changes were not observed in CD, again suggesting disease specificity for axSpA. Given the emerging role of tryptophan and its metabolites in immune function, altogether these data indicate that tryptophan metabolism into I3Ald and then IAA is one mechanism by which the gut microbiome potentially influences the development of axSpA. Frontiers Media S.A. 2021-03-03 /pmc/articles/PMC7966505/ /pubmed/33746944 http://dx.doi.org/10.3389/fimmu.2021.587119 Text en Copyright © 2021 Berlinberg, Regner, Stahly, Brar, Reisz, Gerich, Fennimore, Scott, Freeman and Kuhn http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Berlinberg, Adam J.
Regner, Emilie H.
Stahly, Andrew
Brar, Ana
Reisz, Julie A.
Gerich, Mark E.
Fennimore, Blair P.
Scott, Frank I.
Freeman, Alison E.
Kuhn, Kristine A.
Multi ‘Omics Analysis of Intestinal Tissue in Ankylosing Spondylitis Identifies Alterations in the Tryptophan Metabolism Pathway
title Multi ‘Omics Analysis of Intestinal Tissue in Ankylosing Spondylitis Identifies Alterations in the Tryptophan Metabolism Pathway
title_full Multi ‘Omics Analysis of Intestinal Tissue in Ankylosing Spondylitis Identifies Alterations in the Tryptophan Metabolism Pathway
title_fullStr Multi ‘Omics Analysis of Intestinal Tissue in Ankylosing Spondylitis Identifies Alterations in the Tryptophan Metabolism Pathway
title_full_unstemmed Multi ‘Omics Analysis of Intestinal Tissue in Ankylosing Spondylitis Identifies Alterations in the Tryptophan Metabolism Pathway
title_short Multi ‘Omics Analysis of Intestinal Tissue in Ankylosing Spondylitis Identifies Alterations in the Tryptophan Metabolism Pathway
title_sort multi ‘omics analysis of intestinal tissue in ankylosing spondylitis identifies alterations in the tryptophan metabolism pathway
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966505/
https://www.ncbi.nlm.nih.gov/pubmed/33746944
http://dx.doi.org/10.3389/fimmu.2021.587119
work_keys_str_mv AT berlinbergadamj multiomicsanalysisofintestinaltissueinankylosingspondylitisidentifiesalterationsinthetryptophanmetabolismpathway
AT regneremilieh multiomicsanalysisofintestinaltissueinankylosingspondylitisidentifiesalterationsinthetryptophanmetabolismpathway
AT stahlyandrew multiomicsanalysisofintestinaltissueinankylosingspondylitisidentifiesalterationsinthetryptophanmetabolismpathway
AT brarana multiomicsanalysisofintestinaltissueinankylosingspondylitisidentifiesalterationsinthetryptophanmetabolismpathway
AT reiszjuliea multiomicsanalysisofintestinaltissueinankylosingspondylitisidentifiesalterationsinthetryptophanmetabolismpathway
AT gerichmarke multiomicsanalysisofintestinaltissueinankylosingspondylitisidentifiesalterationsinthetryptophanmetabolismpathway
AT fennimoreblairp multiomicsanalysisofintestinaltissueinankylosingspondylitisidentifiesalterationsinthetryptophanmetabolismpathway
AT scottfranki multiomicsanalysisofintestinaltissueinankylosingspondylitisidentifiesalterationsinthetryptophanmetabolismpathway
AT freemanalisone multiomicsanalysisofintestinaltissueinankylosingspondylitisidentifiesalterationsinthetryptophanmetabolismpathway
AT kuhnkristinea multiomicsanalysisofintestinaltissueinankylosingspondylitisidentifiesalterationsinthetryptophanmetabolismpathway